GLAXOSMITHKLINE LLC recorded 534 award actions and 2.09 billion in obligated federal spend over the last 5 years, with an average action value of 3,909,740.31. The account is concentrated in Department of the Army awards and pharmaceutical preparation manufacturing, with additional activity in biotechnology R&D and medical product categories.
Federal Contractor
GLAXOSMITHKLINE LLC Federal Contract Obligations (Last 5 Years)
Federal procurement profile for GLAXOSMITHKLINE LLC (CAGE 667E9, UEI FRHTPHMZMX47) covering obligations, agencies, NAICS, and year-by-year award activity over the last 5 years.
Totals reflect the selected analysis window and may differ from individual award record values due to rounding and data refresh timing.
CAGE Code
667E9
UEI
FRHTPHMZMX47
Total Obligated
2.09 billion
2,087,801,328.41
Award Actions
534
Average Action Value
3,909,740.31
About GLAXOSMITHKLINE LLC federal contract activity
Over the last 5 years, GLAXOSMITHKLINE LLC recorded 534 FPDS awards totaling $2.09 billion, with an average award value of $3.91 million. The profile is heavily weighted toward a small number of large obligations, indicating a mix of high-value procurement actions rather than a broadly dispersed award base.
Agency mix and customer concentration
The DEPT OF THE ARMY dominates the vendor’s federal business, accounting for $1.87 billion across 35 awards, or the vast majority of obligated dollars in the period. Secondary activity is concentrated in ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE and DEFENSE LOGISTICS AGENCY, which together add meaningful volume but remain well below Army spending; the remaining agencies represent comparatively small shares.
Industry profile based on NAICS activity
Contract activity is centered on NAICS 325412, Pharmaceutical Preparation Manufacturing, which accounts for $1.94 billion across 383 awards. The next largest categories are biotechnology R&D under NAICS 541714 and surgical and medical instrument manufacturing under NAICS 339112, while the remaining NAICS codes contribute only marginal amounts by comparison.
Annual contract trend over the analysis window
Obligations were highly concentrated in 2021 and 2022, with $969.63 million and $1.01 billion obligated in those years respectively. Activity then dropped sharply in 2023 and remained much lower in 2024 and 2025, suggesting a pronounced peak period followed by materially reduced annual spending.
How to interpret this page
This summary is based on FPDS award records associated with CAGE 667E9 and UEI FRHTPHMZMX47 over the last 5 years. Metrics reflect obligated dollars and award counts captured in the analysis window; annual, agency, and NAICS figures are summarized from the provided dataset and may reflect FPDS reporting structure rather than vendor revenue.
Top Agencies
SELECT
agency_id,
agency_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__purchaserInformation__contractingOfficeAgencyID AS agency_id,
anyHeavy(content__award__purchaserInformation__contractingOfficeAgencyID__name) AS agency_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '667E9'
AND content__award__purchaserInformation__contractingOfficeAgencyID IS NOT NULL
AND content__award__purchaserInformation__contractingOfficeAgencyID != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY agency_id
)
ORDER BY total_obligated DESC
LIMIT 10| Agency ID | Agency Name | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 2100 | DEPT OF THE ARMY | 1,871,408,655.78 | 1.87 billion | 35 |
| 7505 | ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE | 133,931,081.79 | 133.93 million | 104 |
| 97AS | DEFENSE LOGISTICS AGENCY | 70,196,826.51 | 70.20 million | 174 |
| 7527 | INDIAN HEALTH SERVICE | 3,447,197.76 | 3.45 million | 7 |
| 1900 | STATE, DEPARTMENT OF | 3,215,634.99 | 3.22 million | 12 |
| 7523 | CENTERS FOR DISEASE CONTROL AND PREVENTION | 1,848,865.02 | 1.85 million | 43 |
| 3600 | VETERANS AFFAIRS, DEPARTMENT OF | 1,642,254.75 | 1.64 million | 36 |
| 1549 | FEDERAL BUREAU OF INVESTIGATION | 1,171,014.53 | 1.17 million | 20 |
| 7001 | OFFICE OF PROCUREMENT OPERATIONS | 516,000.00 | 516.00 thousand | 4 |
| 1540 | FEDERAL PRISON SYSTEM / BUREAU OF PRISONS | 318,600.38 | 318.60 thousand | 78 |
Insight
Over the last 5 years, GLAXOSMITHKLINE LLC’s obligations of $2.09 billion were highly concentrated at the DEPT OF THE ARMY, which accounted for $1.87 billion across 35 awards, or roughly 90% of total obligated dollars. The next largest funding sources were much smaller in dollar value but more distributed by count: the Administration for Strategic Preparedness and Response obligated $133.93 million across 104 awards and the Defense Logistics Agency obligated $70.20 million across 174 awards. Remaining agencies each contributed less than $4 million apiece, indicating a steep drop-off in spending outside the Army and a broad but low-dollar secondary customer base.
Top NAICS
SELECT
naics_code,
naics_name,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
content__award__productOrServiceInformation__principalNAICSCode AS naics_code,
anyHeavy(content__award__productOrServiceInformation__principalNAICSCode__description) AS naics_name,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '667E9'
AND content__award__productOrServiceInformation__principalNAICSCode IS NOT NULL
AND content__award__productOrServiceInformation__principalNAICSCode != ''
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY naics_code
)
ORDER BY total_obligated DESC
LIMIT 10| NAICS Code | Description | Total Obligated | Readable | Award Actions |
|---|---|---|---|---|
| 325412 | PHARMACEUTICAL PREPARATION MANUFACTURING | 1,944,683,419.90 | 1.94 billion | 383 |
| 541714 | RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY) | 107,425,385.99 | 107.43 million | 68 |
| 339112 | SURGICAL AND MEDICAL INSTRUMENT MANUFACTURING | 30,502,860.00 | 30.50 million | 7 |
| 325414 | BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING | 2,958,677.05 | 2.96 million | 35 |
| 325411 | MEDICINAL AND BOTANICAL MANUFACTURING | 1,570,250.73 | 1.57 million | 18 |
| 493120 | REFRIGERATED WAREHOUSING AND STORAGE | 347,786.90 | 347.79 thousand | 12 |
| 423450 | MEDICAL, DENTAL, AND HOSPITAL EQUIPMENT AND SUPPLIES MERCHANT WHOLESALERS | 325,440.43 | 325.44 thousand | 7 |
| 339999 | ALL OTHER MISCELLANEOUS MANUFACTURING | 2,448.75 | 2.45 thousand | 1 |
| 339113 | SURGICAL APPLIANCE AND SUPPLIES MANUFACTURING | -4,332.38 | -4.33 thousand | 2 |
| 446110 | PHARMACIES AND DRUG STORES | -10,608.96 | -10.61 thousand | 1 |
Insight
Over the last 5 years, GLAXOSMITHKLINE LLC’s obligations are highly concentrated in NAICS 325412, Pharmaceutical Preparation Manufacturing, which accounts for $1.94 billion of $2.09 billion total obligated, across 383 of 534 awards. The next largest category, NAICS 541714 for biotechnology R&D, is a distant second at $107.43 million and 68 awards, indicating a sharp drop-off after the core pharmaceutical manufacturing line of business. Remaining obligations are comparatively small and dispersed across medical manufacturing, warehousing, and wholesale categories, with a few minor negative obligation entries in 339113 and 446110.
Annual Trend
SELECT
year,
total_obligated,
award_count,
formatReadableQuantity(total_obligated) AS total_obligated_readable
FROM
(
SELECT
toYear(parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate)) AS year,
sum(content__award__dollarValues__obligatedAmount) AS total_obligated,
count() AS award_count
FROM fpds.data
WHERE
contract_type = 1
AND content__award__vendor__vendorSiteDetails__entityIdentifiers__cageCode = '667E9'
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) >= toStartOfYear(now()) - INTERVAL 5 YEAR
AND parseDateTimeBestEffortOrNull(content__award__relevantContractDates__signedDate) < toStartOfYear(now())
GROUP BY year
)
ORDER BY year DESC| Year | Total Obligated | Readable | Award Actions |
|---|---|---|---|
| 2025 | 29,898,698.95 | 29.90 million | 52 |
| 2024 | 62,713,697.07 | 62.71 million | 153 |
| 2023 | 18,566,762.98 | 18.57 million | 59 |
| 2022 | 1,006,991,125.58 | 1.01 billion | 201 |
| 2021 | 969,631,043.83 | 969.63 million | 69 |
Insight
Over the last 5 years, GLAXOSMITHKLINE LLC obligated $2.09 billion across 534 awards, with activity highly concentrated in 2021 and 2022. Those two years account for nearly all obligations, at $969.63 million in 2021 and $1.01 billion in 2022, compared with substantially lower levels in 2023 through 2025. Award volume was also highest in 2022 and 2024, indicating that dollar value and award count did not move in lockstep across the period.
Use FPDS Query for deeper contractor analysis
Explore federal procurement data with custom SQL, fast filtering, and deeper contractor analysis across buying agencies, NAICS, and annual trends.
Continue from this last 5 years view into full FPDS Query workflows with deeper filtering, custom SQL, saved queries, and broader market comparison.